FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

The man appointed by the Canadian government to help stop fentanyl from entering the United States says his goal is to ...

A federal judge has ordered the Trump administration to reinstate content that was recently removed from the Centers for ...

Federal health agencies have restored several webpages and datasets, following a judge's order to bring back public access to information that had been removed to comply with a presidential executive ...

Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...

NKGen Biotech (NKGN) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation, FTD, for the investigation ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...